NCT07781618

Brief Summary

The number of people with diabetes mellitus worldwide is increasing rapidly and is expected to rise to 439 million by 2030, or 7.7% of the total adult world population. The complications that can arise as a result of chronic diabetes represent a major problem in terms of clinical treatment, socio-economic consequences and costs to the health care system. One of the most serious complications is a diabetic foot, which is characterized by neuropathy, ischemia and limited joint mobility and makes the foot vulnerable to foot ulcers and possible amputation. Various interventions are being investigated to prevent foot ulcers, including custom-made foot orthotics (CFOs), also known as foot orthoses. The latter allows the health professional to achieve a number of functional effects, of which the redistribution of the plantar pressure load is the most valuable, especially in patients with so-called risk feet. The use of integrated computer-aided design and computer-aided manufacturing systems to produce CFOs has become increasingly popular over the past decade. In practice, this digital workflow comprises three different phases. First the (3D) foot shape of the patient is recorded, then the arch support is designed using special software and finally the device is made using a subtractive or additive manufacturing process (3D printing). As a result, it can be concluded that the first two phases are decisive for determining the geometric characteristics of a CFO, while the last phase is more critical for selecting the material properties. As for the first phase, digital approaches were developed, such as 3D optical scanning that allows the researcher to scan body parts directly, providing a robust base for determining a CFO's geometrical features. The anthropometric foot parameters examined were worth investigating, but exclusively zero-dimensional in nature, providing limited insight when assessing the 3D fit of a custom made foot orthotic. Thus, current knowledge in this area remains scarce and further efforts are needed to better understand the role of 'geometrical features' in dose-response characteristics of custom orthotics. With regard to the production phase, additive manufacturing or 3D printing is gaining more and more attention and could potentially set a new standard for manufacturing CFOs. Limited research shows that 3D printed CFOs can be used to reduce plantar pressure in healthy and diabetic populations. However, it is important to mention that these studies have not fully exploited the possible complex design options that the additive manufacturing process can provide, as their designs are very similar to those used in less polyvalent subtractive manufacturing processes. In addition, the relief properties of previously described CFOs are not or rarely driven by patient-specific plantar pressure data. Research design Prospective monocentric observational study with a healthy, asymptomatic population. Objectives The main aim of this study is to evaluate the pressure distribution principle of custom orthotics in asymptomatic adults. The study consists of two parts:

  • Reliability study
  • Observational study Reliability study The methodological part of the current study consists of a reliability study with the focus on scanning the human foot. Since capturing the foot shape is the first step in the manufacturing process of custom insoles, it is important to use a reliable and objective scanning technique. This study aims to test the reliability, more specifically the intra-, inter-rater and test-retest reliability, of a portable, optical 3D scanner. In addition to the traditional zero-dimensional anthropometric measurements of the foot, mainly one-dimensional outcome measures will be studied. Observational study In the observational part, the pressure distribution mechanism of several 3D-printed CFOs on the plantar pressure in asymptomatic patients with a so-called M2-M3 (metatarsal head of the second and third toe) pressure pattern at the level of the forefoot. There is a limited amount of literature on the effect of custom 3D-printed foot orthotics on plantar pressure distribution in healthy populations. In addition, the currently available literature appears to contain heterogeneous groups of participants with different plantar pressure distribution patterns, which complicates correct interpretation and generalization of the results, as the same orthosis designs are used for different pressure distribution patterns. During this study, several custom 3D-printed insoles, differentiated in padding density, structural architecture and geometric shape, will be applied to participants with M2-M3 forefoot patterns and then documented with a pressure distribution alg. Finally, a durability study will be conducted with the custom sole that provides the best relief from the peak pressure area of the forefoot.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Oct 2023

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2023

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 19, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 24, 2026

Completed
Last Updated

August 24, 2026

Status Verified

August 1, 2026

Enrollment Period

2.6 years

First QC Date

August 19, 2026

Last Update Submit

August 19, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Effect of custom-made foot orthotics on plantar pressure in people with a M2-3 pressure pattern.

    The main aim of this study is to evaluate the pressure distribution principle of custom orthotics in asymptomatic adults with a M2-3 pressure pattern.

    From enrollment to the end of the of the test at 6 weeks.

  • Reliability of 3D scanning

    To evaluate the inter-, intra-rater and test-retest reliability of 3D surface scanning for measuring and recording human foot shape in a non-weight bearing condition.

    From enrollment to final scanning after 3 days.

Study Arms (1)

Within-Participant Orthotic Comparison

EXPERIMENTAL

The study still has one experimental arm; the different orthoses are intervention conditions within that arm. It is a single-group, within-participant repeated-measures design.

Other: Foot orthotics

Interventions

Foot orthotics

Within-Participant Orthotic Comparison

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy population, age 18-65-year-old

You may not qualify if:

  • No injury of trauma of the lower limb in the past 6 months
  • No surgical procedures of the lower limbs or back in the past 6 months
  • Not pregnant at the time of testing
  • No (auto) immune system disorders with a possible impact on the feet (e.g., rheumatoid arthritis)
  • No systemic or neurological disorder
  • Interventional study
  • Healthy population, age 18-65-year-old
  • Maximum weight of 90 kg
  • In-shoe M2 - M3 or central pattern bilateral or left/right
  • No injury of trauma of the lower limb in the past 6 months
  • No surgical procedures of the lower limbs or back in the past 6 months
  • Not pregnant at the time of testing
  • No (auto) immune system disorders with a possible impact on the feet (e.g., rheumatoid arthritis)
  • No systemic or neurological disorder
  • Work does not require wearing safety shoes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KU Leuven Campus Bruges

Bruges, West-Flanders, 8200, Belgium

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Prospective monocentric observational study with a healthy, asymptomatic population.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2026

First Posted

August 24, 2026

Study Start

October 23, 2023

Primary Completion

June 4, 2026

Study Completion

August 19, 2026

Last Updated

August 24, 2026

Record last verified: 2026-08

Locations